Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nucleic acid flow cytometry in large cell lymphoma.

P McLaughlin1, B M Osborne, D Johnston

  • 1Department of Hematology, University of Texas, M.D. Anderson Hospital and Tumor Institute, Houston 77030.

Cancer Research
|November 15, 1988
PubMed
Summary

DNA-RNA cytometry in large cell lymphoma patients reveals key prognostic factors. Intermediate RNA content and diploid DNA predict better outcomes with intensive chemotherapy, aiding treatment decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

Leukemia·2018
Same author

Drug response prediction in high-risk multiple myeloma.

Gene·2017
Same author

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Nature communications·2017
Same author

Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.

Leukemia·2017
Same author

NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma.

Leukemia·2017
Same author

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker.

Blood cancer journal·2017

Area of Science:

  • Oncology
  • Hematology
  • Cell Biology

Background:

  • Large cell lymphoma (LCL) encompasses various subtypes including follicular, diffuse, immunoblastic, and transformed lymphomas.
  • Accurate prognostic factors are crucial for tailoring treatment strategies in LCL.
  • Established prognostic indicators may not fully capture the heterogeneity of LCL.

Purpose of the Study:

  • To evaluate the prognostic value of DNA-RNA cytometry in patients with large cell lymphoma.
  • To correlate DNA-RNA features with treatment outcomes and compare them to existing prognostic factors.
  • To identify patient subsets with a high likelihood of cure using intensive chemotherapy.

Main Methods:

  • DNA-RNA cytometry was performed on involved tissue from 140 LCL patients (1978-1985).

Related Experiment Videos

  • Prognostic factors were analyzed in 63 newly diagnosed patients receiving intensive therapy.
  • DNA-RNA features were correlated with treatment outcome and compared to established factors.

    • Main Results:

    • Patients with intermediate RNA content (RNA index, 1.0-1.8) and diploid DNA content showed significantly better outcomes.
    • Low proliferative activity during the initial 12 months was associated with a better prognosis.
    • Multivariate analysis identified RNA content as the most significant prognostic factor, followed by proliferative activity and LDH.

    Conclusions:

    • DNA-RNA cytometry is a valuable prognostic tool for large cell lymphoma.
    • Intermediate RNA content and diploid DNA are favorable prognostic indicators for intensive chemotherapy.
    • This technique helps identify LCL patients likely to achieve a cure with intensive treatment.